Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland

The introduction of pneumococcal conjugate vaccines (PCVs) into childhood vaccination programs has reduced carriage of vaccine serotypes and pneumococcal disease. The 10-valent PCV was introduced in Iceland in 2011.

Bibliographic Details
Published in:	Journal of Clinical Microbiology
Main Authors:	Quirk, Sigríður J., Haraldsson, Gunnsteinn, Hjálmarsdóttir, Martha Á., van Tonder, Andries J., Hrafnkelsson, Birgir, Bentley, Stephen D., Haraldsson, Ásgeir, Erlendsdóttir, Helga, Brueggemann, Angela B., Kristinsson, Karl G.
Other Authors:	Diekema, Daniel J., The Wellcome Trust Research Fellowship, Wellcome core funding grant, Landspitali University Hospital Research Fund, The Eimskip University Fund, GlaxoSmithKline, Oxford University \| John Fell Fund, University of Oxford
Format:	Article in Journal/Newspaper
Language:	English
Published:	American Society for Microbiology 2019
Subjects:	Iceland
Online Access:	http://dx.doi.org/10.1128/jcm.01766-18 https://journals.asm.org/doi/pdf/10.1128/JCM.01766-18

Description
Summary:	The introduction of pneumococcal conjugate vaccines (PCVs) into childhood vaccination programs has reduced carriage of vaccine serotypes and pneumococcal disease. The 10-valent PCV was introduced in Iceland in 2011.